ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China
Indian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health ministry for procurement of pharmaceuticals for its hospitals, according to the India-China Economic and Cultural Counc
Announcement as on 11 November 2025

Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche plea
The Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular atrophy. This decision overturns a previous stay, allowing Natco to offer the medication at a significantly lower pric
Announcement as on 09 October 2025

Natco Pharma's Kothur unit classified as 'voluntary action indicated' by US regulator
Natco Pharma Ltd announced that its Kothur unit in Hyderabad received an Establishment Inspection Report (EIR) from the US FDA, classifying the facility as 'Voluntary Action Indicated' (VAI). The US FDA had previously conducted an inspection of the company
Announcement as on 18 September 2025

Natco Pharma sues Novo Nordisk in generic drug push
The lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its non-infringing patents but received no response, said people familiar with the matter. "A clear communication from t
Announcement as on 21 August 2025

Natco Pharma launches generic drug with 180-day exclusivity in US
Natco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young patients. This launch comes with 180-day exclusivity. Lupin Ltd. is Natco's marketing partner for this product. The d
Announcement as on 20 August 2025

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 796.26
  • 12Day Average: 818.08
  • 20Day Average: 817.37
  • 50Day Average: 856.63
  • 100Day Average: 908.57
  • 150Day Average: 957.67
  • 200Day Average: 937.47

524816 Indicators & signals

Indicator MACD (12,26,9)

808.86, 825.5, -14.36
Indicator MACD is in negative zone

Indicator ADX (14)

45.26, 9.67, 25.66
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.61 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 0.89 times
13 Tue Oct 2026 789.60 787.50 to 803.55 -1.32% 0.34 times
12 Mon Oct 2026 800.20 789.10 to 804.15 -2.85% 1.1 times
06 Tue Oct 2026 823.70 815.55 to 826.00 0.19% 0.74 times
05 Mon Oct 2026 822.15 801.35 to 827.65 0.05% 1.05 times
01 Thu Oct 2026 821.75 803.30 to 826.75 -2.63% 0.76 times
29 Tue Sep 2026 843.95 827.90 to 851.65 1.91% 0.82 times
28 Mon Sep 2026 828.10 824.00 to 856.30 -1.42% 1.83 times
25 Fri Sep 2026 840.05 835.00 to 850.20 -0.21% 0.53 times
24 Thu Sep 2026 841.85 831.15 to 855.00 0.48% 1.93 times
23 Wed Sep 2026 837.85 811.90 to 840.00 2.81% 0.62 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top